Notes
Country of occurrence, reporter country and primary source country not stated.
Reference
Zghaib T, et al. PO-683-06 MULTICENTER EXPERIENCE WITH ANDEXANET ALFA FOR REFRACTORY PERICARDIAL BLEEDING DURING CATHETER ABLATION OF ATRIAL FIBRILLATION IN PATIENTS TAKING FACTOR XA INHIBITORS. Heart Rhythm 19 (Suppl.): S370-S371 (plus poster) abstr. PO-683-06, No. 5, May 2022. Available from: URL: https://www.sciencedirect.com/science/article/pii/S154752712200755X?via%3Dihub [abstract]
Rights and permissions
About this article
Cite this article
Andexanet alfa. Reactions Weekly 1910, 40 (2022). https://doi.org/10.1007/s40278-022-16875-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-16875-y